111 related articles for article (PubMed ID: 37348310)
1. The effect of numeric information about the likelihood of receiving a false negative or false positive result on people's attitudes towards colorectal cancer screening using faecal immunochemical testing (FIT).
Miles A; Paschalidi A; Sharma N
Patient Educ Couns; 2023 Sep; 114():107857. PubMed ID: 37348310
[TBL] [Abstract][Full Text] [Related]
2. The effect of information about false negative and false positive rates on people's attitudes towards colorectal cancer screening using faecal occult blood testing (FOBt).
Miles A; Rodrigues V; Sevdalis N
Patient Educ Couns; 2013 Nov; 93(2):342-9. PubMed ID: 23850021
[TBL] [Abstract][Full Text] [Related]
3. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
Steele RJC; Digby J; Chambers JA; O'Carroll RE
BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
[TBL] [Abstract][Full Text] [Related]
4. Role of demographics in noninvasive testing for colorectal cancer screening: do targeted cut-off values improve detection?
Gill I; Shams C; Hanna A; George J; Jamil LH; Patel A
Minerva Gastroenterol (Torino); 2023 Dec; 69(4):459-469. PubMed ID: 35343664
[TBL] [Abstract][Full Text] [Related]
5. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
6. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.
Ibáñez-Sanz G; Garcia M; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Domènech X; Vidal C; Soriano A; Moreno V;
Dig Liver Dis; 2016 Oct; 48(10):1249-54. PubMed ID: 27378703
[TBL] [Abstract][Full Text] [Related]
7. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.
Ibañez-Sanz G; Garcia M; Milà N; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Benito L; Padrol I; Barenys M; Moreno V
Eur J Cancer Prev; 2017 Sep; 26(5):365-367. PubMed ID: 27433880
[TBL] [Abstract][Full Text] [Related]
8. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
9. Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.
Ibáñez-Sanz G; Milà N; de la Peña-Negro LC; Garcia M; Vidal C; Rodríguez-Alonso L; Binefa G; Rodríguez-Moranta F; Moreno V
J Gastroenterol; 2021 Jan; 56(1):42-53. PubMed ID: 33159805
[TBL] [Abstract][Full Text] [Related]
10. Impact of including quantitative information in a decision aid for colorectal cancer screening: A randomized controlled trial.
Schwartz PH; Imperiale TF; Perkins SM; Schmidt KK; Althouse S; Rawl SM
Patient Educ Couns; 2019 Apr; 102(4):726-734. PubMed ID: 30578103
[TBL] [Abstract][Full Text] [Related]
11. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
12. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
[TBL] [Abstract][Full Text] [Related]
13. Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).
Denters MJ; Deutekom M; Essink-Bot ML; Bossuyt PM; Fockens P; Dekker E
Health Expect; 2015 Oct; 18(5):839-49. PubMed ID: 23432931
[TBL] [Abstract][Full Text] [Related]
14. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
15. Training primary care physicians to offer their patients faecal occult blood testing and colonoscopy for colorectal cancer screening on an equal basis: a pilot intervention with before-after and parallel group surveys.
Selby K; Cornuz J; Gachoud D; Bulliard JL; Nichita C; Dorta G; Ducros C; Auer R
BMJ Open; 2016 May; 6(5):e011086. PubMed ID: 27178977
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
[TBL] [Abstract][Full Text] [Related]
17. Effects of Promotional Materials on Attitudes and Fear towards Colorectal Cancer Screening among Chinese Older Adults: An Experimental Study.
Leung DYP; Chen JMT; Lou VWQ; Wong EML; Chan AWK; So WKW; Chan CWH
Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28703752
[TBL] [Abstract][Full Text] [Related]
18. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
Toft EL; Kaae SE; Malmqvist J; Brodersen J
Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
[No Abstract] [Full Text] [Related]
20. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
